Rezultati - Stewart Goldman
- Showing 1 - 20 results of 65
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients od Jeffrey P. Gross, Stephanie Powell, Frank Zelko, William F. Hartsell, Stewart Goldman, Jason Fangusaro, Rishi Lulla, Natasha Pillay Smiley, John Chang, Vinai Gondi
Izdano 2019Artigo -
11
-
12
Erratum: The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation od Chandra Das, Pete Taylor, Monica Gireud, Ajay Singh, Dean A. Lee, Gregory N. Fuller, Lingyun Ji, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Charles G. Eberhart, Vidya Gopalakrishnan
Izdano 2016Errata/Corrigenda -
13
REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma od Pete Taylor, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Irene Helenowski, Tobey J. MacDonald, Martin Hasselblatt, Lars Riedemann, Álvaro Macedo Laureano, Laurence J.N. Cooper, Vidya Gopalakrishnan
Izdano 2012Artigo -
14
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Childr... od Stewart Goldman, Éric Bouffet, Paul G. Fisher, Jeffrey C. Allen, Patricia L. Robertson, Paul J. Chuba, Bernadine Donahue, Cynthia S. Kretschmar, Tianni Zhou, Allen Buxton, Ian F. Pollack
Izdano 2015Artigo -
15
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas od Regina I. Jakacki, Eva Dombi, Seth M. Steinberg, Stewart Goldman, Mark W. Kieran, Nicole J. Ullrich, Ian F. Pollack, Anne Goodwin, Peter Manley, Jason Fangusaro, Rudy Allen, Brigitte C. Widemann
Izdano 2016Artigo -
16
Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma od Fabrício F. Costa, Jared M. Bischof, Elio F. Vanin, Rishi Lulla, Min Wang, Simone Treiger Sredni, Veena Rajaram, Maria de Fátima Bonaldo, Deli Wang, Stewart Goldman, Tadanori Tomita, Marcelo B. Soares
Izdano 2011Artigo -
17
A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study od Maryam Fouladi, Clinton F. Stewart, Susan M. Blaney, Arzu Onar‐Thomas, Paula Schaiquevich, Roger J. Packer, Stewart Goldman, J. Russell Geyer, Amar Gajjar, Larry E. Kun, James M. Boyett, Richard J. Gilbertson
Izdano 2013Artigo -
18
Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012 od Tobey J. MacDonald, Clinton F. Stewart, Mehmet Koçak, Stewart Goldman, Richard G. Ellenbogen, Peter C. Phillips∥, Deborah A. Lafond, Tina Young Poussaint, Mark W. Kieran, James M. Boyett, Larry E. Kun
Izdano 2008Artigo -
19
Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study od Amar Gajjar, Clinton F. Stewart, David W. Ellison, Sue C. Kaste, Larry E. Kun, Roger J. Packer, Stewart Goldman, Murali Chintagumpala, Dana Wallace, Naoko Takebe, James M. Boyett, Richard J. Gilbertson, Tom Curran
Izdano 2013Artigo -
20
Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group od Katherine E. Warren, Tina Young Poussaint, Gilbert Vézina, Darren Hargrave, Roger J. Packer, Stewart Goldman, Patrick Y. Wen, Ian F. Pollack, David Zurakowski, Larry E. Kun, Michael D. Prados, Stefan Rutkowski, Mark W. Kieran
Izdano 2013Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Oncology
Surgery
Cancer research
Pathology
Chemotherapy
Gastroenterology
Biology
Glioma
Cancer
Clinical trial
Radiation therapy
Gene
Medulloblastoma
Ependymoma
Genetics
Neurofibromatosis
Astrobiology
Pharmacokinetics
Physics
Refractory (planetary science)
Toxicity
Adverse effect
Biochemistry
Phases of clinical research
Gene expression
Pediatrics
Progressive disease
Radiology